日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation

多发性骨髓瘤患者自体干细胞移植风险分层系统

Guo, Wancheng; Strouse, Christopher; Mery, David; Siegel, Eric R; Munshi, Manit N; Ashby, Timothy Cody; Cheng, Yan; Sun, Fumou; Wanchai, Visanu; Zhang, Zijun; Bailey, Clyde; Alapat, Daisy V; Peng, Hongling; Al Hadidi, Samer; Thanendrarajan, Sharmilan; Schinke, Carolina; Zangari, Maurizio; van Rhee, Frits; Tricot, Guido; Shaughnessy, John D Jr; Zhan, Fenghuang

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS

在阿肯色大学医学科学中心(UAMS)接受自体干细胞移植治疗的多发性骨髓瘤患者中应用R2-ISS风险分层。

Guo, Wancheng; Zhan, Anne; Mery, David E; Munshi, Manit N; Makhoul, Oussama; Baily, Clyde; Zangari, Maurizio; Tricot, Guido; Peng, Hongling; Shaughnessy, John D Jr

Venetoclax in Previously Treated Waldenström Macroglobulinemia

维奈托克用于既往接受过治疗的华氏巨球蛋白血症

Castillo, Jorge J; Allan, John N; Siddiqi, Tanya; Advani, Ranjana H; Meid, Kirsten; Leventoff, Carly; White, Timothy P; Flynn, Catherine A; Sarosiek, Shayna; Branagan, Andrew R; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Xu, Lian; Yang, Guang; Patterson, Christopher J; Hunter, Zachary R; Davids, Matthew S; Furman, Richard R; Treon, Steven P

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

对初治华氏巨球蛋白血症患者进行伊布替尼单药治疗的长期随访

Castillo, Jorge J; Meid, Kirsten; Gustine, Joshua N; Leventoff, Carly; White, Timothy; Flynn, Catherine A; Sarosiek, Shayna; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Xu, Lian; Yang, Guang; Branagan, Andrew R; O'Donnell, Elizabeth; Raje, Noopur; Yee, Andrew J; Patterson, Christopher J; Hunter, Zachary R; Treon, Steven P

Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy

对伊布替尼单药治疗产生耐药性后,Waldenström巨球蛋白血症的自然病程

Gustine, Joshua N; Sarosiek, Shayna; Flynn, Catherine A; Meid, Kirsten; Leventoff, Carly; White, Timothy; Guerrera, Maria Luisa; Xu, Lian; Kofides, Amanda; Tsakmaklis, Nicholas; Munshi, Manit; Demos, Maria; Patterson, Christopher J; Liu, Xia; Yang, Guang; Hunter, Zachary R; Branagan, Andrew R; Treon, Steven P; Castillo, Jorge J

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

SRC家族激酶HCK在MYD88突变淋巴瘤中作为SYK激活驱动因子的新作用

Munshi, Manit; Liu, Xia; Kofides, Amanda; Tsakmaklis, Nickolas; Guerrera, Maria Luisa; Hunter, Zachary R; Palomba, M Lia; Argyropoulos, Kimon V; Patterson, Christopher J; Canning, Alexa G; Meid, Kirsten; Gustine, Joshua; Branagan, Andrew R; Flynn, Catherine A; Sarosiek, Shayna; Castillo, Jorge J; Wang, Jinhua; Buhrlage, Sara J; Gray, Nathanael S; Munshi, Nikhil C; Anderson, Kenneth C; Treon, Steven P; Yang, Guang

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia

伊布替尼联合CXCR4拮抗剂ulocuplumab治疗CXCR4突变型华氏巨球蛋白血症的I期研究

Treon, Steven P; Meid, Kirsten; Hunter, Zachary R; Flynn, Catherine A; Sarosiek, Shayna R; Leventoff, Carly R; White, Timothy P; Cao, Yang; Roccaro, Aldo M; Sacco, Antonio; Demos, Maria G; Guerrera, Maria Luisa; Kofides, Amanda; Liu, Xia; Xu, Lian; Patterson, Christopher J; Munshi, Manit; Tsakmaklis, Nicholas; Yang, Guang; Ghobrial, Irene M; Branagan, Andrew R; Castillo, Jorge J

Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88(L265P) in Waldenström Macroglobulinemia

诊断性二代测序经常无法检测到华氏巨球蛋白血症中的MYD88(L265P)突变

Kofides, Amanda; Hunter, Zachary R; Xu, Lian; Tsakmaklis, Nicholas; Demos, Maria G; Munshi, Manit; Liu, Xia; Guerrera, Maria Luisa; Leventoff, Carly R; White, Timothy P; Flynn, Catherine A; Meid, Kirsten; Patterson, Christopher J; Yang, Guang; Branagan, Andrew R; Sarosiek, Shayna; Castillo, Jorge J; Treon, Steven P; Gustine, Joshua N

Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib

在接受伊布替尼治疗的华氏巨球蛋白血症患者中,6 个月时达到部分缓解或更佳疗效预示着更长的无进展生存期。

Castillo, Jorge J; Abeykoon, Jithma P; Gustine, Joshua N; Zanwar, Saurabh; Mein, Kirsten; Flynn, Catherine A; Demos, Maria G; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nickolas; King, Rebecca; Yang, Guang; Hunter, Zachary R; Advani, Ranjana H; Palomba, Maria Lia; Ansell, Stephen M; Gertz, Morie A; Kapoor, Prashant; Treon, Steven P

Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemia

骨髓受累和亚克隆多样性会降低华氏巨球蛋白血症患者通过诊断性二代测序检测突变型 CXCR4 的能力。

Gustine, Joshua N; Xu, Lian; Yang, Guang; Liu, Xia; Kofides, Amanda; Tsakmaklis, Nicholas; Munshi, Manit; Demos, Maria; Guerrera, Maria L; Meid, Kirsten; Patterson, Christopher J; Sarosiek, Shayna; Branagan, Andrew R; Hunter, Zachary R; Castillo, Jorge J; Treon, Steven P